Sarah Pirrie

7PUBLICATIONS
57CO-AUTHORS
Cancer cell biologyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 31, 2025
Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action.

Veronica Nanton, Richard T Bryan, Anne M Pope

|Jan 14, 2025
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.

Richard T Bryan, Wenyu Liu, Sarah J Pirrie

|Sep 09, 2024
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.

Nicholas James, Sarah Pirrie, Wenyu Liu

|Oct 21, 2022
Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer.

Nicholas D James, Ayesha Ali, Ann Pope

|Jul 31, 2022
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer.

Nicholas D James, Wenyu Liu, Sarah Pirrie

|Jul 15, 2021
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.

Stelios Chrysostomou, Rajat Roy, Filippo Prischi

Pageof 2